ID 79184
著者
兼松, 貴則 Department of Medical Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School
埴淵, 昌毅 Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School KAKEN研究者をさがす
富本, 英樹 Department of Medical Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School
先山, 正二 Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School KAKEN研究者をさがす
監崎, 孝一郎 Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School
近藤, 和也 Department of Oncological Medical Services, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
坂東, 弘康 Department of Respiratory Medicine, Tokushima Prefectural Central Hospital
ハク, タカシ Department of Respiratory Medicine, Tokushima Prefectural Central Hospital
ヨネダ, カズオ Department of Respiratory Medicine, Tokushima Prefectural Central Hospital
広瀬, 敏幸 Department of Surgery, Tokushima Prefectural Central Hospital
豊田, 優子 Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
後東, 久嗣 Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
坂口, 暁 Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School
木下, 勝弘 Department of Medical Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School KAKEN研究者をさがす
東, 桃代 Department of Medical Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
柿内, 聡司 Department of Medical Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School KAKEN研究者をさがす
岸, 潤 Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School KAKEN研究者をさがす
吾妻, 雅彦 Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
タダ, ヒロヤ Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School
住友, 正幸 Department of Surgery, Tokushima Prefectural Central Hospital
西岡, 安彦 Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
矢野, 聖二 Department of Medical Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School|Division of Medical Oncology, Cancer Research Institute, Kanazawa University
曽根, 三郎 Department of Medical Oncology, Institute of Health Biosciences, the University of Tokushima Graduate School|Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
キーワード
epidemiology
lung cancer
Tokushima Prefecture
資料タイプ
学術雑誌論文
抄録
Lung cancer is the leading cause of malignancy-related death worldwide. In
the present study, we reviewed the epidemiologic and clinical features of lung cancer in
Tokushima Prefecture, Japan. Between January 1999 and December 2009, 2,183 patients
with lung cancer were enrolled in this study. One thousand five hundred ninety-one (73%)
patients were male and 592 (27%) patients were female. Median age was 70 years, with a
range of 15-93 years. Seventy-six percent of patients had smoking history. One thousand
nine hundred five (87%) patients were non-small cell lung cancer and the predominant histological
type was adenocarcinoma (51%). Among all 2,183 patients, 702 (32%) belonged to
elderly population. Four hundred seventy-one (22%), 213 (10%), 24 (1%), 116 (5%), 238 (11%),
370 (17%) and 678 (31%) patients had stage IA, IB, IIA, IIB, IIIA, IIIB and IV lung cancer, respectively.
In Tokushima University Hospital, 516 (29%), 191 (11%), 58 (3%), 755 (43%) and
216 (12%) patients were initially treated with chemotherapy, chemo-radiotherapy, thoracic
radiotherapy, operation and best supportive care, respectively. The median time to
progression (TTP) and the median survival time (MST) of patients treated with chemotherapy
and chemo-radiotherapy were 3.5 months, 13.0 months and 7.0 months, 18.0 months,
respectively. The median TTP and the MST of 33 elderly patients treated with chemotherapy
were 3.3 months and 18.0 months, respectively, which were comparable with those of
total population. These results indicated the benefit of chemotherapy in elderly patients
with advanced lung cancer by proper selection.
掲載誌名
The journal of medical investigation : JMI
ISSN
13431420
cat書誌ID
AA11166929
57
3-4
開始ページ
326
終了ページ
333
並び順
326
発行日
2010-08
備考
The journal of medical investigation : http://medical.med.tokushima-u.ac.jp/jmi/index.html
EDB ID
239731
フルテキストファイル
言語
eng
部局
医学系
病院